Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Reiman

Showing results (291-300 of 434) with videos related to

Pageof 44
Sort By:
Biorxiv : the Preprint Server for Biology|November 14, 2023
A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's diseaseQi Wang, Jerry Antone, Eric Alsop, et al.
Annals of Neurology|March 11, 2011
CR1 is associated with amyloid plaque burden and age-related cognitive declineLori B Chibnik, Joshua M Shulman, Sue E Leurgans, et al.
Applied Neuropsychology. Adult|June 25, 2019
Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registryValeria L Torres, Clara Vila-Castelar, Yamile Bocanegra, et al.
Human Molecular Genetics|February 21, 2012
A coding variant in CR1 interacts with APOE-ε4 to influence cognitive declineBrendan T Keenan, Joshua M Shulman, Lori B Chibnik, et al.
American Journal of Human Genetics|February 11, 2021
Genetic control of the human brain proteomeChloe Robins, Yue Liu, Wen Fan, et al.
Human Brain Mapping|September 26, 2009
Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometryApril J Ho, Xue Hua, Suh Lee, et al.
JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.
Journal of Alzheimer'S Disease : JAD|August 28, 2023
Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease ColombiaClaudia Ramos, Claudia Madrigal, Daniel Camilo Aguirre-Acevedo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohortPierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
Pageof 44

Showing results (291-300 of 434) with videos related to

Sort By:
Pageof 44
Biorxiv : the Preprint Server for Biology|November 14, 2023
A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's diseaseQi Wang, Jerry Antone, Eric Alsop, et al.
Annals of Neurology|March 11, 2011
CR1 is associated with amyloid plaque burden and age-related cognitive declineLori B Chibnik, Joshua M Shulman, Sue E Leurgans, et al.
Applied Neuropsychology. Adult|June 25, 2019
Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registryValeria L Torres, Clara Vila-Castelar, Yamile Bocanegra, et al.
Human Molecular Genetics|February 21, 2012
A coding variant in CR1 interacts with APOE-ε4 to influence cognitive declineBrendan T Keenan, Joshua M Shulman, Lori B Chibnik, et al.
American Journal of Human Genetics|February 11, 2021
Genetic control of the human brain proteomeChloe Robins, Yue Liu, Wen Fan, et al.
Human Brain Mapping|September 26, 2009
Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometryApril J Ho, Xue Hua, Suh Lee, et al.
JAMA Neurology|July 23, 2019
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical TrialChristopher H van Dyck, Haakon B Nygaard, Kewei Chen, et al.
Journal of Alzheimer'S Disease : JAD|August 28, 2023
Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease ColombiaClaudia Ramos, Claudia Madrigal, Daniel Camilo Aguirre-Acevedo, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohortPierre N Tariot, Francisco Lopera, Jessica B Langbaum, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
Pageof 44